206 related articles for article (PubMed ID: 16300148)
1. The effect of "xanthinol niacinate" on platelet aggregation.
Balkuv S; Akman N; Ulutin ON
New Istanbul Contrib Clin Sci; 1967; 9(2):49-51. PubMed ID: 16300148
[No Abstract] [Full Text] [Related]
2. Effect of xanthinol nicotinate treatment on platelet aggregation.
Seidel G; Endell W
Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):139-43. PubMed ID: 844933
[TBL] [Abstract][Full Text] [Related]
3. [Antiaggregant properties of new 1,3,4-thiadiazine derivatives].
Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perov NM; Rusinov VL
Eksp Klin Farmakol; 2009; 72(5):27-30. PubMed ID: 19928572
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic and antiplatelet action of xanthinol nicotinate (Sadamin): possible mechanisms.
Bieroń K; Swies J; Kostka-Trabka E; Gryglewski RJ
J Physiol Pharmacol; 1998 Jun; 49(2):241-9. PubMed ID: 9670107
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Complamin on fibrinolysis and platelet aggregation in the aged].
Matijević N; Sisić I; Korolija P; Pendić B
Bilt Hematol Transfuz; 1980; 8(1):37-43. PubMed ID: 7337681
[TBL] [Abstract][Full Text] [Related]
6. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
7. A new method of representing drug-induced platelet inhibition: better description of time course, response variability, non-response, and heightened activity.
Gurbel PA; Bliden KP
Platelets; 2003; 14(7-8):481-3. PubMed ID: 14713517
[No Abstract] [Full Text] [Related]
8. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
9. [The antiaggregant activity of the synthetic antioxidant emoxipin].
Stoliarov VA; Repin AN; Markov VA
Eksp Klin Farmakol; 1993; 56(2):35-6. PubMed ID: 8348036
[TBL] [Abstract][Full Text] [Related]
10. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
Pampuch A; Cerletti C; de Gaetano G
Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
[TBL] [Abstract][Full Text] [Related]
11. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
[TBL] [Abstract][Full Text] [Related]
12. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.
Geisler T; Anders N; Paterok M; Langer H; Stellos K; Lindemann S; Herdeg C; May AE; Gawaz M
Diabetes Care; 2007 Feb; 30(2):372-4. PubMed ID: 17259513
[No Abstract] [Full Text] [Related]
13. [The effect of melatonin on thrombocyte aggregation in healthy subjects].
Evsiukova EV; Petrishchev NN
Fiziol Cheloveka; 1998; 24(6):122-5. PubMed ID: 9929964
[No Abstract] [Full Text] [Related]
14. [Diltiazem and modulation of platelet aggregation].
Colica G; Salnitro D; Scopelliti F; Sergi D; Pellegrino R; Zoccali A; Lanucara P
Minerva Cardioangiol; 1990; 38(1-2):51-4. PubMed ID: 2342647
[TBL] [Abstract][Full Text] [Related]
15. Effect of prostaglandins and drotaverine on ADP-induced platelet aggregation.
Losonczy H; Nagy I; Gregus Z
Acta Med Acad Sci Hung; 1974; 31(3-4):157-63. PubMed ID: 4469713
[No Abstract] [Full Text] [Related]
16. Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom.
Lopez-Johnston JC; de Bosch N; Scannone H; Rodríguez-Acosta A
Ann Hematol; 2007 Dec; 86(12):879-85. PubMed ID: 17891398
[TBL] [Abstract][Full Text] [Related]
17. [The effect of new synthetic prostanoids on the aggregation activity of human thrombocytes].
Petrukhina GN; Makarova VA; FReĭmanis IaF; Lozha EV
Eksp Klin Farmakol; 1995; 58(6):45-8. PubMed ID: 8704613
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
19. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
20. [Effect of a micellar preparation of polyunsaturated phosphatidylcholine on platelet aggregation in vitro].
Vlasova II; Torkhovskaia TI; Fortinskaia ES; Khalilov EM; Azizova OA
Biull Eksp Biol Med; 1996 Feb; 121(2):199-203. PubMed ID: 9026131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
